These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8195025)

  • 1. Does DNA targeting affect the cytotoxicity and cell uptake of basic nitroquinoline bioreductive drugs?
    Siim BG; Denny WA; Wilson WR
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):311-5. PubMed ID: 8195025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and radiolytic reduction of 4-alkylamino-5-nitroquinoline bioreductive drugs. Relationship to hypoxia-selective cytotoxicity.
    Siim BG; Atwell GJ; Wilson WR
    Biochem Pharmacol; 1994 Oct; 48(8):1593-604. PubMed ID: 7980625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugs.
    Siim BG; Atwell GJ; Anderson RF; Wardman P; Pullen SM; Wilson WR; Denny WA
    J Med Chem; 1997 Apr; 40(9):1381-90. PubMed ID: 9135035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline (5-nitraquine), a new DNA-affinic hypoxic cell radiosensitizer and bioreductive agent: comparison with nitracrine.
    Wilson WR; Siim BG; Denny WA; van Zijl PL; Taylor ML; Chambers DM; Roberts PB
    Radiat Res; 1992 Sep; 131(3):257-65. PubMed ID: 1438685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen dependence of the cytotoxicity and metabolic activation of 4-alkylamino-5-nitroquinoline bioreductive drugs.
    Siim BG; Atwell GJ; Wilson WR
    Br J Cancer; 1994 Oct; 70(4):596-603. PubMed ID: 7917903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolism.
    Siim BG; Hicks KO; Pullen SM; van Zijl PL; Denny WA; Wilson WR
    Biochem Pharmacol; 2000 Oct; 60(7):969-78. PubMed ID: 10974206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient redox cycling of nitroquinoline bioreductive drugs due to aerobic nitroreduction in Chinese hamster cells.
    Siim BG; Wilson WR
    Biochem Pharmacol; 1995 Jun; 50(1):75-82. PubMed ID: 7605348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bis-bioreductive agents as hypoxia-selective cytotoxins: nitracrine N-oxide.
    Wilson WR; Van Zijl P; Denny WA
    Int J Radiat Oncol Biol Phys; 1992; 22(4):693-6. PubMed ID: 1544839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)butanamide (NSC 639862), a bisnitroimidazole with enhanced selectivity as a bioreductive drug.
    Moselen JW; Hay MP; Denny WA; Wilson WR
    Cancer Res; 1995 Feb; 55(3):574-80. PubMed ID: 7834627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity.
    Lee HH; Wilson WR; Denny WA
    Anticancer Drug Des; 1999 Dec; 14(6):487-97. PubMed ID: 10834270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
    J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aliphatic amine N-oxides of DNA binding agents as bioreductive drugs.
    Patterson LH; Craven MR; Fisher GR; Teesdale-Spittle P
    Oncol Res; 1994; 6(10-11):533-8. PubMed ID: 7620222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the nitro functionality in the DNA binding of 3-nitro-10-methylbenzothiazolo[3,2-a]quinolinium chloride.
    Colón IG; González FA; Cordero M; Zayas B; Velez C; Cox O; Kumar A; Alegría AE
    Chem Res Toxicol; 2008 Sep; 21(9):1706-15. PubMed ID: 18759504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitizing and toxic properties of quinoline and nitroquinoline complexes of platinum [PtCl2(NH3)quinoline].
    Skov KA; Adomat H; Doedee M; Farrell N
    Anticancer Drug Des; 1994 Apr; 9(2):103-17. PubMed ID: 8166927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-targeted 1,2,4-benzotriazine 1,4-dioxides: potent analogues of the hypoxia-selective cytotoxin tirapazamine.
    Hay MP; Pruijn FB; Gamage SA; Liyanage HD; Kovacs MS; Patterson AV; Wilson WR; Brown JM; Denny WA
    J Med Chem; 2004 Jan; 47(2):475-88. PubMed ID: 14711317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic studies of enhanced in vitro radiosensitization and hypoxic cell cytotoxicity by targeting radiosensitizers to DNA via intercalation.
    Cowan DS; Kanagasabapathy VM; McClelland RA; Rauth AM
    Int J Radiat Oncol Biol Phys; 1992; 22(3):541-4. PubMed ID: 1735693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.
    Papadopoulou MV; Bloomer WD
    Anticancer Drugs; 2009 Jul; 20(6):493-502. PubMed ID: 19430289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of low pH and hypoxia on the cytotoxic effects of SR4233 and mitomycin C in vitro.
    Skarsgard LD; Vinczan A; Skwarchuk MW; Chaplin DJ
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):363-7. PubMed ID: 8195034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.